A comprehensive overview of pneumococcal vaccination recommendations for adults in South Africa, 2022.

ABSTRACT: Pneumococcal infections remain a common global cause of significant morbidity and mortality. The first recommendations for adult pneumococcal vaccination, published in South Africa in 1999, contained information only on the 23-valent polysaccharide vaccine (PPV23). With the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in adults and the perceived uncertainty that most clinicians had regarding use of these vaccines in adults, these vaccine recommendations were updated in 2022. A Working Group, which consisted of individuals in various fields of medical practice in South Africa, who were from different areas of the country, and included clinicians from both the public and private sectors, was assembled to revise the recommendations. The expertise of the partici

SUBMITTER: Feldman C 

PROVIDER: S-EPMC9641319 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature